News & Updates

Pre-treatment neutrophil-to-lymphocyte ratio (NLR) values appear to be correlated with overall and disease-free survival in patients with cholangiocarcinoma, reports a recent meta-analysis.

The past two decades have seen a disproportionate increase in cases of early-onset, well-differentiated neuroendocrine neoplasms (age 20‒34 years) compared with other age groups, driven primarily by midgut tumours, according to a recent study.

Photodynamic therapy using topically applied hypericin 0.25% is effective against early-stage patch and plaque lesions in patients with mycosis fungoides−cutaneous T-cell lymphoma, while having a favourable safety profile, as shown in the phase III FLASH trial.

Surgical treatment for metastatic disease of bone (MDB) at lower-volume hospitals is not associated with poorer survival or more readmissions, according to a study.

The addition of erlotinib to best supportive care (BSC) provided better survival benefit than BSC only in individuals with unresectable/metastatic gall bladder cancer (GBC) with poor performance status (PS), according to a phase II/III open-label study.